Intervacc AB (OSTO:IVACC) DeferredTaxAndRevenue: kr0.00 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:IVACC Intervacc AB OSTO:IVACC
63 GF Score
Price kr1.22
GF Value kr1.10
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Intervacc AB DeferredTaxAndRevenue?

Intervacc AB OSTO:IVACC -3.62% 63 DeferredTaxAndRevenue is kr0.00 Mil as of Mar. 2026. GuruFocus rates OSTO:IVACC with a GF Score™ of 63/100 and a GF Value™ of kr1.10 (Modestly Overvalued). The stock has 5 warning signs investors should review.

Deferred Tax And Revenue represents the current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Intervacc AB's current deferred tax and revenue for the quarter that ended in Mar. 2026 was kr0.00 Mil.

Intervacc AB DeferredTaxAndRevenue Related Terms

Intervacc AB DeferredTaxAndRevenue Historical Data

* Premium members only.

The historical data trend for Intervacc AB's DeferredTaxAndRevenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Intervacc AB DeferredTaxAndRevenue Chart

Intervacc AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
DeferredTaxAndRevenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Intervacc AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
DeferredTaxAndRevenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
OSTO:IVACC
63GF Score
Intervacc AB OSTO:IVACC
DeferredTaxAndRevenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about DeferredTaxAndRevenue →
What does a DeferredTaxAndRevenue of kr0.00 Mil mean?
Intervacc AB (OSTO:IVACC) has a DeferredTaxAndRevenue of kr0.00 Mil as of Mar. 2026. Deferred tax and revenue represents the current portion of taxes and unearned revenue that are now past due. View historical data on Intervacc AB.
Is Intervacc AB's DeferredTaxAndRevenue too high?
Intervacc AB's current DeferredTaxAndRevenue is kr0.00 Mil. Overall, Intervacc AB has a GF Score™ of 63/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Intervacc AB's DeferredTaxAndRevenue compare to VRTX and REGN?
Intervacc AB's DeferredTaxAndRevenue of kr0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good DeferredTaxAndRevenue for a Biotechnology company?
A good DeferredTaxAndRevenue depends on the Biotechnology industry context. However, DeferredTaxAndRevenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high DeferredTaxAndRevenue mean?
A high DeferredTaxAndRevenue can signal that a stock is expensive relative to its fundamentals. Deferred tax and revenue represents the current portion of taxes and unearned revenue that are now past due. View historical data on Intervacc AB. Intervacc AB's current DeferredTaxAndRevenue is kr0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Intervacc AB stock overvalued right now?
Based on GuruFocus' analysis, Intervacc AB (OSTO:IVACC) is currently considered Modestly Overvalued. The stock's GF Value™ is kr1.10, compared to a current price of kr1.22 — trading 11.3% above its estimated fair value. The current DeferredTaxAndRevenue is kr0.00 Mil. Intervacc AB's overall GF Score™ is 63/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is DeferredTaxAndRevenue calculated?
DeferredTaxAndRevenue is calculated from a company's financial statements. For Intervacc AB (OSTO:IVACC), the current DeferredTaxAndRevenue is kr0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Intervacc AB (OSTO:IVACC) Overvalued in 2026?

Based on GuruFocus' analysis, Intervacc AB stock appears to be overvalued. The current stock price of kr1.22 is trading 11.3% above its estimated GF Value™ of kr1.10. GuruFocus considers Intervacc AB to be Modestly Overvalued.

Key valuation signals for OSTO:IVACC:

  • DeferredTaxAndRevenue: kr0.00 Mil
  • GF Value™: kr1.10 vs. price of kr1.22 (11.3% above fair value)
  • GF Score™: 63/100 with 5 warning signs

No single metric tells the full story. See the OSTO:IVACC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Intervacc AB Business Description

Address Vastertorpsvagen 135, Hagersten, Stockholm, SWE, S-129 44
Intervacc AB is a biotechnology company. It develops new vaccines based on recombinant proteins to meet the increasing need for effective vaccines in animal health care. The company through its subsidiary focuses on diagnostics in the Swedish animal health market and offers bacteriological and mycological analyses on the Swedish market.
63GF Score

Get the complete analysis for OSTO:IVACC

DeferredTaxAndRevenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr1.22
Price
kr1.10
GF Value